Histoplasmosis Treatment Stopped Early in Study
Immunocompromised adults saw low relapse rates after ending antifungal therapy before 12 months.
U.S. Diseases — General
Recent news
September 23, 2026
Monopar Initiated Drug Submission for Wilson DiseaseThe application for ALXN1840 marks a step toward a new treatment option for those living with this rare genetic disorder.
September 22, 2026
FDA Cleared New Three-in-One Respiratory TestThe new diagnostic identifies COVID, flu, and RSV using a single swab, providing clarity when symptoms overlap.
September 21, 2026
Cornell Researchers Developed Portable Ebola-Lassa TestA new diagnostic tool detects viral proteins from a single drop of blood to help clarify early symptoms.
September 19, 2026
Excess RNA Impaired Mitochondrial Energy ProductionResearchers found that RNA accumulation disrupts cellular energy, a discovery that could improve future mRNA-based medicine.